These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

969 related articles for article (PubMed ID: 27838465)

  • 1. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
    Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
    Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling.
    Ping Z; Wang Z; Shi J; Wang L; Guo X; Zhou W; Hu X; Wu X; Liu Y; Zhang W; Yang H; Xu Y; Gu Y; Geng D
    Acta Biomater; 2017 Oct; 62():362-371. PubMed ID: 28867647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling pathway.
    Ping Z; Hu X; Wang L; Shi J; Tao Y; Wu X; Hou Z; Guo X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
    Acta Biomater; 2017 Mar; 51():513-525. PubMed ID: 28088671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway.
    Ouyang Z; Zhai Z; Li H; Liu X; Qu X; Li X; Fan Q; Tang T; Qin A; Dai K
    Biochem Pharmacol; 2014 Aug; 90(3):276-87. PubMed ID: 24950468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccarin prevents titanium particle-induced osteolysis and inhibits RANKL-induced osteoclastogenesis by blocking NF-κB and MAPK signaling pathways.
    Liu Y; Song FM; Ma ST; Moro A; Feng WY; Liao SJ; Lin XX; Zhao JM; Wang ZY; Xu J; Zhan XL; Liu Q
    J Cell Physiol; 2019 Aug; 234(8):13832-13842. PubMed ID: 30637734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of titanium-particle-induced inflammatory osteolysis after local administration of dopamine and suppression of osteoclastogenesis via D2-like receptor signaling pathway.
    Yang H; Xu Y; Zhu M; Gu Y; Zhang W; Shao H; Wang Y; Ping Z; Hu X; Wang L; Geng D
    Biomaterials; 2016 Feb; 80():1-10. PubMed ID: 26695376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arctigenin inhibits RANKL-induced osteoclastogenesis and hydroxyapatite resorption in vitro and prevents titanium particle-induced bone loss in vivo.
    Wei G; Liang T; Wei C; Nong X; Lu Q; Zhao J
    J Cell Biochem; 2019 Apr; 120(4):5367-5376. PubMed ID: 30317692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amentoflavone Inhibits Osteoclastogenesis and Wear Debris-Induced Osteolysis via Suppressing NF-κB and MAPKs Signaling Pathways.
    Zhang Z; Zhao S; Li X; Zhuo X; Zhang W; Nie Q; Wang S; Yan L; Sun Y
    Planta Med; 2018 Jul; 84(11):759-767. PubMed ID: 29301147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentamidine Inhibits Titanium Particle-Induced Osteolysis
    Ihn HJ; Kim K; Cho HS; Park EK
    Tissue Eng Regen Med; 2019 Jun; 16(3):265-273. PubMed ID: 31205855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of RANKL-induced osteoclastogenesis through the suppression of p38 signaling pathway by naringenin and attenuation of titanium-particle-induced osteolysis.
    Wang W; Wu C; Tian B; Liu X; Zhai Z; Qu X; Jiang C; Ouyang Z; Mao Y; Tang T; Qin A; Zhu Z
    Int J Mol Sci; 2014 Nov; 15(12):21913-34. PubMed ID: 25464380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro.
    Wu C; Wang W; Tian B; Liu X; Qu X; Zhai Z; Li H; Liu F; Fan Q; Tang T; Qin A; Zhu Z
    Biochem Pharmacol; 2015 Jan; 93(1):59-71. PubMed ID: 25449599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption.
    Wang L; Guo X; Zhou W; Ding Y; Shi J; Wu X; Liu Y; Xu Y; Yang H; Geng D
    Acta Biomater; 2018 Jun; 73():488-499. PubMed ID: 29656074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of enoxacin on osteoclastogenesis and reduction of titanium particle-induced osteolysis via suppression of JNK signaling pathway.
    Liu X; Qu X; Wu C; Zhai Z; Tian B; Li H; Ouyang Z; Xu X; Wang W; Fan Q; Tang T; Qin A; Dai K
    Biomaterials; 2014 Jul; 35(22):5721-30. PubMed ID: 24767789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade.
    Zhang L; Yang Y; Liao Z; Liu Q; Lei X; Li M; Saijilafu ; Zhang Z; Hong D; Zhu M; Li B; Yang H; Chen J
    Theranostics; 2020; 10(15):6638-6660. PubMed ID: 32550895
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin inhibits osteoclast formation and wear-debris-induced bone destruction by suppressing mitogen-activated protein kinases.
    Shi J; Wang Z; Guo X; Shen J; Sun H; Bai J; Yu B; Wang L; Zhou W; Liu Y; Zhang W; Yang H; Xu Y; Zhou J; Geng D
    J Cell Physiol; 2020 Mar; 235(3):2599-2608. PubMed ID: 31498438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevention of titanium-particle-induced osteolysis by OA-14 through the suppression of the p38 signaling pathway and inhibition of osteoclastogenesis.
    Tian B; Jiang T; Shao Z; Zhai Z; Li H; Fan Q; Liu X; Ouyang Z; Tang T; Jiang Q; Zheng M; Dai K; Qin A; Yu Y; Zhu Z
    Biomaterials; 2014 Oct; 35(32):8937-50. PubMed ID: 25086794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geraniin suppresses RANKL-induced osteoclastogenesis in vitro and ameliorates wear particle-induced osteolysis in mouse model.
    Xiao F; Zhai Z; Jiang C; Liu X; Li H; Qu X; Ouyang Z; Fan Q; Tang T; Qin A; Gu D
    Exp Cell Res; 2015 Jan; 330(1):91-101. PubMed ID: 25016282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of wear particle-induced osteolysis by a novel V-ATPase inhibitor saliphenylhalamide through inhibition of osteoclast bone resorption.
    Qin A; Cheng TS; Lin Z; Cao L; Chim SM; Pavlos NJ; Xu J; Zheng MH; Dai KR
    PLoS One; 2012; 7(4):e34132. PubMed ID: 22509274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scutellarin inhibits RANKL-mediated osteoclastogenesis and titanium particle-induced osteolysis via suppression of NF-κB and MAPK signaling pathway.
    Zhao S; Sun Y; Li X; Wang J; Yan L; Zhang Z; Wang D; Dai J; He J; Wang S
    Int Immunopharmacol; 2016 Nov; 40():458-465. PubMed ID: 27728897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jatrorrhizine Hydrochloride Suppresses RANKL-Induced Osteoclastogenesis and Protects against Wear Particle-Induced Osteolysis.
    Li H; Wang J; Sun Q; Chen G; Sun S; Ma X; Qiu H; Liu X; Xu L; Liu M
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.